Daptomycin Spectrum and Clinical Applications

Antimicrobial Spectrum and Clinical Use

• The Infectious Diseases Society of America recommends daptomycin as an alternative to vancomycin for gram-positive coverage in specific clinical scenarios 1
• When treating infections where gram-negative coverage is needed, daptomycin must be combined with appropriate gram-negative active agents, as stated by the World Journal of Emergency Surgery 2
• For infections potentially involving both gram-positive and gram-negative organisms, daptomycin must be combined with agents that provide gram-negative coverage, according to the World Journal of Emergency Surgery 2
• In neutropenic patients with fever, if gram-positive coverage is needed, daptomycin can be used as an alternative to vancomycin but must be combined with appropriate gram-negative active antibiotics, as recommended by the Infectious Diseases Society of America 3
• For empiric therapy in settings where both gram-positive and gram-negative coverage is required, combination therapy is necessary when daptomycin is selected for the gram-positive component, as stated by the Infectious Diseases Society of America 1
• In hospital-acquired or ventilator-associated pneumonia where gram-negative coverage is critical, daptomycin should not be used as monotherapy due to its lack of gram-negative activity, according to the European Respiratory Society 4
• For severe infections in immunocompromised patients, broad-spectrum coverage including specific agents for gram-negative bacteria must accompany daptomycin, as recommended by the Infectious Diseases Society of America 5